The MDR1 (multidrug resistance 1) gene mutation is a significant genetic condition that can affect a dog’s ability to process certain common medications, potentially leading to severe or even fatal adverse reactions. This mutation is particularly prevalent in herding breeds, such as Collies, Shetland Sheepdogs, and Australian Shepherds, but it can also be found in other breeds and mixed-breed dogs. Understanding the MDR1 status of your dog is crucial for ensuring their safety when medical treatment is necessary. This article delves into the nature of the MDR1 mutation, the breeds most commonly affected, and the medications that pose a risk to these sensitive dogs.
The Impact of the MDR1 Mutation on Dogs
The MDR1 gene provides instructions for making a protein called P-glycoprotein. This protein acts as a pump in cell membranes, actively transporting a variety of drugs and other foreign substances out of cells, including those in the brain. In dogs with the MDR1 mutation, this P-glycoprotein transporter functions improperly, meaning certain drugs can accumulate in the body, particularly in the brain, reaching toxic levels.
Up to 75% of some dog breeds, including herding breeds like Collies and long-haired whippets, carry the MDR1 genetic mutation. This genetic predisposition means that a significant portion of these populations may experience adverse drug reactions. Washington State University (WSU) is a leading institution in identifying drugs that are dangerous for dogs with this mutation and in developing safer alternative treatments.
Problem Medications and Safe Alternatives
The list of medications that can cause adverse reactions in dogs with the MDR1 mutation is continuously updated based on peer-reviewed research. It is essential for owners and veterinarians to consult the most current information. Some key medications and their recommendations include:
- Loperamide (Imodium): At doses used for diarrhea, this drug can cause severe neurological toxicity in dogs with the MDR1 mutation and should be avoided entirely.
- Ivermectin: While commonly found in heartworm preventatives like Heartgard Plus, it is generally considered safe at label doses for dogs with the MDR1 mutation, as confirmed by the FDA. However, other formulations of ivermectin may require different dosing or should be avoided.
- Chemotherapy Drugs (e.g., Doxorubicin, Vinblastine, Vincristine): These drugs require careful management. Consulting with specialists like those at MDR1Caddie™ is crucial for determining appropriate dosages or alternative treatments.
- Acepromazine, Butorphanol, Apomorphine, Maropitant, Ondansetron: For these and other medications, specific dosing recommendations or alternative drugs should be discussed with a veterinary pharmacologist.
Manufacturers of certain flea and tick medications, such as Nexgard (afoxolaner), Bravecto (fluralaner), Simparica (sarolaner), and products containing moxidectin (like ProHeart and Simparica Trio), have conducted safety tests in dogs with the MDR1 mutation and found no adverse effects at label doses. Similarly, Interceptor (milbemycin) and Revolution (selamectin) have been deemed safe by the FDA when used as directed.
Identifying Affected Breeds
The MDR1 mutation is most frequently observed in breeds with herding backgrounds. Approximately 70% of Collies in the United States are estimated to carry the mutation. Other breeds with a high prevalence include:
- Australian Shepherds (approximately 50%)
- Miniature Australian Shepherds (approximately 50%)
- Long-haired Whippets (approximately 50%)
- Silken Windhounds (approximately 30%)
- McNab (approximately 30%)
- Shetland Sheepdogs (approximately 15%)
- English Shepherds (approximately 15%)
- German Shepherds (approximately 10%)
- Herding Breed Crosses (approximately 10%)
While less common, the mutation can also appear in mixed-breed dogs, with an estimated frequency of around 5%. Even breeds not typically associated with the mutation, like Saint Bernards and Siberian Huskies, have been identified as carrying it.
The Importance of Testing and Management
The only definitive way to determine if a dog has the MDR1 gene mutation is through genetic testing. Washington State University offers accurate genetic testing, and as more dogs are tested, the understanding of affected breeds continues to expand. If your dog requires medication, it is vital to inform your veterinarian about their MDR1 status. If your dog’s status is unknown, genetic testing is highly recommended, especially if your dog belongs to a breed with a higher prevalence of the mutation.
Veterinary pharmacologist Dr. Katrina Mealey, who discovered the MDR1 genetic mutation, and her team at WSU, can assist through MDR1Caddie™. This service provides guidance to owners and veterinarians on managing medications for dogs with the MDR1 mutation, helping to ensure appropriate and safe treatment plans.
Conclusion
The MDR1 gene mutation presents a unique challenge in canine healthcare, highlighting the importance of personalized medicine. By understanding the genetic predispositions of certain breeds and advocating for genetic testing, dog owners can work collaboratively with their veterinarians to navigate medication choices safely. This proactive approach ensures that dogs receive the necessary treatments while minimizing the risk of dangerous drug interactions, ultimately contributing to a longer, healthier life for our canine companions. Early detection and informed management are key to safeguarding dogs affected by the MDR1 mutation.